taxonomy (3)
protein (22)
source (4)
structure (2)
composition (1)
disease (4)
reference (4)
site (39)
peptide (60)
- Homo sapiens (Human)
- Naja kaouthia (Monocled cobra)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Aminopeptidase n / Homo sapiens P15144
- Attractin / Homo sapiens O75882
- CD166 antigen / Homo sapiens Q13740
- Cell adhesion molecule 1 / Homo sapiens Q9BY67
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens Q9Y5L3
- Endothelin-converting enzyme 1 / Homo sapiens P42892
- Haptoglobin / Homo sapiens P00738
- Inactive tyrosine-protein kinase 7 / Homo sapiens Q13308
- Kininogen-1 / Homo sapiens P01042
- Laminin subunit gamma-1 / Homo sapiens P11047
- Lysosome membrane protein 2 / Homo sapiens Q14108
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- N-acetylglucosamine-6-sulfatase / Homo sapiens P15586
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Receptor tyrosine-protein kinase erbB-2 / Homo sapiens P04626
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Tenascin / Homo sapiens P24821
- Transmembrane glycoprotein NMB / Homo sapiens Q14956
- Cobra venom factor / Naja kaouthia Q91132
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Venom (UBERON_0007113)
- HEK293 (CVCL_0045)
Source
- N-Linked / Complex / Structure 452
- N-Linked / Complex / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-4)]Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
Reported structure
- Hex:7 HexNAc:6 dHex:5 (avg mass : 3102.8971 )
Composition
- Cancer, breast (DOID:1612)
- Carcinoma (DOID:305)
- Carcinoma, Hepatocellular (DOID:684)
- COVID-19 (DOID:0080600)
Disease
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins (2014 - Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R.) / Status : Reviewed
- N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures. (2001 - Gowda DC, Glushka J, van-Halbeek H , Thotakura RN, Bredehorst R, Vogel C-W) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Attractin / Homo sapiens
- CD166 antigen / Homo sapiens
- Cell adhesion molecule 1 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- N-acetylglucosamine-6-sulfatase / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Receptor tyrosine-protein kinase erbB-2 / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Tenascin / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
-
Cobra venom factor / Naja kaouthia
- Undefined site
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- FVFLVLLPLVSSQCVNLTTR (20aa)
- LFLPFFSNVTWFHAIHVSGTNGTKR (25aa)
- FLPFFSNVTWFHAIHVSGTNGTK (23aa)
- VSGTNGTK (8aa)
- TNGTKR (6aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- FQIINFSSSEIK (12aa)
- VSITNVSISDEGR (13aa)
- SANASFNIK (9aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNK (37aa)
- GTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLR (35aa)
- NNKSW (5aa)
- NNKSWMESEFRVYSSANNCTFE (22aa)
- NNKSWMESEFRVYSSANNCTF (21aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFL (29aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMDL (32aa)
- GNFSTEGCGCVCEPGWK (17aa)
- NGTNDGDYVFITGEDSYINFTK (22aa)
- NDRNSSDETFIK (12aa)
- IININPNK (8aa)
- NAIKEGDNITIK (12aa)
- EGDNITIK (8aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- LLGGGDEEAIRPQMQQILDFETALANITIPQEK (33aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFN (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNR (36aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IIDNNKTEK (9aa)
- NATVVWMK (8aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- IAVDWESIGYNITR (14aa)
- NVTDPTCPSLSPGVSQCFPDCVCEDAYNNTYACVR (35aa)
- YSVLIMAEKPVGDLSSPNETK (21aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILP (38aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPV (39aa)
- YSNNSIAIPTNFTISVTTEILPVSMTK (27aa)
- NATLVNEADK (10aa)
- AATCINPINGSVCERPANHSAK (22aa)
- NFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPEL (38aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- NHTSPDVDLGDISGINASVVNIQKEIDR (28aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- YFKNHTSPDVDLGDISGINASVVNIQKEI (29aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- EELDKYFKNHTSPDVDLGDISGIN (24aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLC (44aa)
- NLNESLIDLQEL (12aa)
- NLNESLIDLQELGKYEQY (18aa)
- TLAGENQTAFEIEELNRK (18aa)
- VEAAQNITIPGSIR (14aa)
- GFEESEPVSGSFTTAIDGPSGIVTANITDSEAIAR (35aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 3102.8971)
- Blood Serum (UBERON_0001977)
- Haptoglobin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 3102.8971)
- Venom (UBERON_0007113)
-
Cobra venom factor / Naja kaouthia
- Undefined site
-
- Hex:7 HexNAc:6 dHex:5 / N-Linked (avg mass : 3102.8971)
- N-Linked / Complex / Structure 452
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Attractin / Homo sapiens
- CD166 antigen / Homo sapiens
- Cell adhesion molecule 1 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- N-acetylglucosamine-6-sulfatase / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Receptor tyrosine-protein kinase erbB-2 / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Tenascin / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FVFLVLLPLVSSQCVNLTTR (20aa)
- LFLPFFSNVTWFHAIHVSGTNGTKR (25aa)
- FLPFFSNVTWFHAIHVSGTNGTK (23aa)
- VSGTNGTK (8aa)
- TNGTKR (6aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- FQIINFSSSEIK (12aa)
- VSITNVSISDEGR (13aa)
- SANASFNIK (9aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNK (37aa)
- GTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLR (35aa)
- NNKSW (5aa)
- NNKSWMESEFRVYSSANNCTFE (22aa)
- NNKSWMESEFRVYSSANNCTF (21aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFL (29aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMDL (32aa)
- GNFSTEGCGCVCEPGWK (17aa)
- NGTNDGDYVFITGEDSYINFTK (22aa)
- NDRNSSDETFIK (12aa)
- IININPNK (8aa)
- NAIKEGDNITIK (12aa)
- EGDNITIK (8aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- LLGGGDEEAIRPQMQQILDFETALANITIPQEK (33aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFN (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNR (36aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IIDNNKTEK (9aa)
- NATVVWMK (8aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- IAVDWESIGYNITR (14aa)
- NVTDPTCPSLSPGVSQCFPDCVCEDAYNNTYACVR (35aa)
- YSVLIMAEKPVGDLSSPNETK (21aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILP (38aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPV (39aa)
- YSNNSIAIPTNFTISVTTEILPVSMTK (27aa)
- NATLVNEADK (10aa)
- AATCINPINGSVCERPANHSAK (22aa)
- NFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPEL (38aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- NHTSPDVDLGDISGINASVVNIQKEIDR (28aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- YFKNHTSPDVDLGDISGINASVVNIQKEI (29aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- EELDKYFKNHTSPDVDLGDISGIN (24aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLC (44aa)
- NLNESLIDLQEL (12aa)
- NLNESLIDLQELGKYEQY (18aa)
- TLAGENQTAFEIEELNRK (18aa)
- VEAAQNITIPGSIR (14aa)
- GFEESEPVSGSFTTAIDGPSGIVTANITDSEAIAR (35aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Reported glycosite
